Archive for Flex Pharma

Flex Pharma Reports Positive RCT Phase 2 MS Study

May 26, 2018

Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS

November 28, 2017

Flex Pharma Announces Positive Phase 2 ALS Results

November 6, 2017